Bexagliflozin
Bexagliflozin is listed in the FDA National Drug Code directory with 6 NDC codes, marketed under brand names including Bexagliflozin, BRENZAVVY. Available dosage forms: tablet, powder.
Drug Details
- Generic Name
- Bexagliflozin
- Brand Names
- Bexagliflozin, BRENZAVVY
- Application Number
- NDA214373
- Sponsor
- Golden State Medical Supply, Inc.
- NDC Codes
- 6
- Dosage Forms
- TABLET, POWDER
- Routes
- ORAL
- Active Ingredients
- BEXAGLIFLOZIN
Indications and Usage
1 INDICATIONS AND USAGE BRENZAVVY is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitations of Use BRENZAVVY is not recommended for use to improve glycemic control in patients with type 1 diabetes mellitus. [see Warnings and Precautions ( 5.1 )] . BRENZAVVY is a sodium-glucose co-transporter 2 (SGLT2) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. ( 1 ) Limitation of Use: Not recommended for use to improve glycemic control in patients with type 1 diabetes mellitus. ( 1 )